With the exception of ADAMTS1 that decreased in 231-VEGF tumors but increased in cells, the increase of uPAR, LOX, MMP1 and a decrease of MMP2 observed in the tumors was also observed in 231_VEGF cells that suggested that the enzymatic changes driving the ECM changes occurred directly within the cancer cells. This evidence concerns the gene VEGFA and cancer.